Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,384 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Unexpected Adverse Events of Immune Checkpoint Inhibitors.
Shalata W, Yakobson A, Cohen AY, Goldstein I, Saleh OA, Dudnik Y, Rouvinov K. Shalata W, et al. Among authors: goldstein i. Life (Basel). 2023 Jul 29;13(8):1657. doi: 10.3390/life13081657. Life (Basel). 2023. PMID: 37629514 Free PMC article.
Vismodegib as First-Line Treatment of Mutated Sonic Hedgehog Pathway in Adult Medulloblastoma.
Kian W, Roisman LC, Goldstein IM, Abo-Quider A, Samueli B, Wallach N, Alguayn F, Shalata W, Levitas D, Belochitski O, Levin D, Fenig E, Lavrenkov K, Tokar M, Peled N, Yakobson A. Kian W, et al. JCO Precis Oncol. 2020 Apr 30;4:PO.19.00264. doi: 10.1200/PO.19.00264. eCollection 2020. JCO Precis Oncol. 2020. PMID: 32923880 Free PMC article. No abstract available.
Carpal Tunnel Syndrome Associated with Immune Checkpoint Inhibitors.
Yakobson A, Rouvinov K, Cohen AY, Goldstein I, Abu Saleh O, Solomon A, Dudnik Y, Shalata W. Yakobson A, et al. Among authors: goldstein i. J Pers Med. 2023 Aug 30;13(9):1340. doi: 10.3390/jpm13091340. J Pers Med. 2023. PMID: 37763109 Free PMC article.
Osimertinib in advanced EGFR-mutant lung adenocarcinoma with asymptomatic brain metastases: an open-label, 3-arm, phase II pilot study.
Peled N, Kian W, Inbar E, Goldstein IM, Zemel M, Rotem O, Rozenblum AB, Nechushtan H, Dudnik E, Levin D, Zer A, Keren-Rosenberg S, Yust-Katz S, Fuchs V, Remilah AA, Shelef I, Roisman LC. Peled N, et al. Among authors: goldstein im. Neurooncol Adv. 2021 Dec 27;4(1):vdab188. doi: 10.1093/noajnl/vdab188. eCollection 2022 Jan-Dec. Neurooncol Adv. 2021. PMID: 35156036 Free PMC article.
1,384 results